# Intravenous Immunoglobulin (IVIG) in Lung Transplantation

> **NCT00115778** · PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 11 (actual)

## Conditions studied

- Hypogammaglobulinemia
- Lung Transplantation

## Interventions

- **DRUG:** IVIG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00115778
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2009-08
- **Final completion:** 2010-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115778, "Intravenous Immunoglobulin (IVIG) in Lung Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00115778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*